About
Categories
- Asia
- Business
- CMS
- Congress
- Deals
- Diagnostics
- Excerpts from "The Silver Sheet"
- FDA
- Feature Stories
- Featured Event
- From the Archives
- Haiti Devices and Supplies Relief
- International
- Interview
- Medtech Innovation
- New Products
- On The Record
- Publisher's Spotlight
- R&D;
- Regulatory
- Reimbursement
- Start-Up News
- Top Device Companies
Recent Posts
- SSI: Revolutionizing Breast Cancer Detection, but Slowly
- Insulin Device Companies' New Mantra: Real Simple
- Device-Based Stroke Intervention: An Interview with Adnan Siddiqui
- St. Jude Draws Warning Letter For Off-label Promotion Of A-Fib Ablation
- FDA Cites Long-Term Precedent In Blocking Retail Genetic Screening Plans
- St. Jude Accused By FDA Of Illegal Promotion Of Epicor Surgery Device
- CDRH Blames Missed Pre-market Review Goals On More Complex Workload
- ECRI Institute Advises Hospitals On CT Radiation Dose Reduction
- FDA Seeks Public/Private Partners For Device Epidemiology Network
- Abbott Ventures: Building A Venture Portfolio in Devices
Notices
- Copyright©2008-2010, F-D-C Reports, Inc. and Windhover Information Inc. All rights reserved.
« CDRH Blames Missed Pre-market Review Goals On More Complex Workload | Main | FDA Cites Long-Term Precedent In Blocking Retail Genetic Screening Plans »
May 17, 2010
St. Jude Accused By FDA Of Illegal Promotion Of Epicor Surgery Device
St. Jude Launches Latest Heart Defibrillator In Europe Market
Medtronic, St. Jude Announce Separate Wireless Heart Device Adapters
Smith & Nephew Continues Strong Sales Growth, Led By BlueSky Unit
Smith & Nephew, DePuy, Wright Eye Coming Changes In U.K. Device Rules
Covidien Cleared To Use Ventilator On Newborns As Small As 11 Ounces
Abbott Says Xience V Stent Compares Favorably With Boston Sci Taxus
Boston Scientific Discloses Subpoenas, Document Request From Feds
Medtronic Reveals Software Bug In Six Models Of Implanted Defibrillators
Medtronic Begins Trial Of Automatic Version Of Neurostimulator
Covidien Chief Says Eying Larger Firms For Acquisitions
Stryker Kickback Case Tossed By Federal Judge Pending Revisions
Genzyme To Sell Diagnostic, Gene Testing, Drug Material Non-Core Units
C.R. Bard Offers Friendly Buyout Of SenoRx For $200 Million
Genzyme To Sell Diagnostic, Gene Testing, Drug Material Non-Core Units
C.R. Bard Offers Friendly Buyout Of SenoRx For $200 Million
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d83452f00669e2013480ef12f6970c
Listed below are links to weblogs that reference St. Jude Accused By FDA Of Illegal Promotion Of Epicor Surgery Device:
The comments to this entry are closed.
Search Medical Devices Today
.jpg)
Device Industry Announcements
- Virginia Tech's Health Product Risk Management Program
Earn a Master of Science in Life Sciences with an Option in Health Product Risk Management from Virginia Tech - Post Your Industry Announcements Here
Contact us to find out you can post an event, announcement or job opening here.
Useful Links
- BioHealth Investor
- BioPharma Today
- Clearstate
- Compliance-Alliance
- Drug Discovery Today
- Elsevier Business Intelligence
- EuroPharma Today
- Eye On FDA
- FDA Law Blog
- IN VIVO
- IN VIVO Blog
- Inteleos
- Medical Device Manufacturers Association
- Medical Devices Today
- Medtech Insight
- Over The Counter Today
- Pharmalot
- PharmAsia News
- RPM REPORT
- Search Company Profiles
- Spicy IP Blog (India)
- Start-Up
- The Gold Sheet
- The Gray Sheet
- The Pink Sheet
- The Pink Sheet DAILY
- The Silver Sheet
- The Tan Sheet
- Top Device Companies
Comments